Erkang Pharmaceuticals: 300267 Erkang Pharmaceutical Investor Relations Management Information 20241010
Erkang Pharmaceutical: Announcement on participating in the 2024 Online Group Reception Day for Investors of Listed Companies in Hunan
Hunan Er-kang Pharmaceutical: 300267 Erkang Pharmaceutical Investor Relations Management Information 20240510
Erkang Pharmaceutical: Resolutions of the First Special Meeting of Independent Directors of the 5th Board of Directors
Erkang Pharmaceuticals: Announcement on changes in accounting policies
Erkang Pharmaceutical: Independent Director Tan Xue's 2023 Debriefing Report
Erkang Pharmaceutical: Feasibility Analysis Report on Launching Hedging Business
Erkang Pharmaceuticals: Board of Directors Special Opinions on the Independent Director Assessment
Erkang Pharmaceuticals: 2023 Annual Audit Report
Erkang Pharmaceuticals: Articles of Association (April 2024)
Erkang Pharmaceuticals: Announcement of Board Resolutions
Erkang Pharmaceuticals: Special Verification Opinions on Revenue Deductions for 2023
Erkang Pharmaceutical: Supervisory Board Resolutions Announcement
Erkang Pharmaceutical: Special Audit Instructions for 2023 Non-operating Capital Occupation and Other Related Capital Transactions
Erkang Pharmaceutical: Independent Director Wang Junwen's 2023 Debriefing Report
Erkang Pharmaceuticals: 2023 Board Work Report
Erkang Pharmaceutical: 2023 Supervisory Committee Work Report
Erkang Pharmaceutical: Independent Director Jiang Wuzhen's 2023 Debriefing Report
Erkang Pharmaceutical: Announcement on applying for a comprehensive credit line from banks in 2024
Erkang Pharmaceuticals: Articles of Association (November 2023)
No Data
No Data